{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:54:06Z","timestamp":1772524446791,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Specialized pro-resolving mediators (SPMs) are bioactive lipids derived from essential fatty acids that play a key role in resolving inflammation and modulating immune responses, thereby maintaining tissue homeostasis in various physiological contexts, including pregnancy. In healthy pregnancies, inflammation is a biological response necessary for vascular remodeling, embryo implantation as well as delivery and an increase in SPMs such as lipoxin A4 (LXA4) and resolvin D1 (RvD1) supports homeostasis and facilitates inflammation resolution. However, pregnancy complications such as spontaneous abortion, fetal growth restriction (FGR), and preeclampsia are often associated with disrupted SPM levels and receptor activity. In spontaneous abortion, altered SPM levels are linked to impaired endometrial receptivity, defective trophoblast invasion, poor epithelial-to-mesenchymal transition, and enhanced inflammation. Similarly, FGR is associated with reduced LXA4 levels, which contribute to placental vascular dysfunction and impaired trophoblast migration. Preeclampsia is characterized by dysregulated SPM levels and a pro-inflammatory environment, indicating insufficient resolutive activity. Therapeutic approaches to enhance SPM levels, such as aspirin-triggered lipoxins and omega-3 fatty acid supplementation, have demonstrated potential benefits. However, inconsistent clinical outcomes highlight the need for personalized treatment strategies. This review explores the role of SPMs in pregnancy, focusing on their molecular mechanisms and the development of targeted supplementation strategies to optimize their protective effects in managing high-risk pregnancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key messages<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Physiological pregnancies involve a gradual increase in SPM levels.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>LXA4 and RvD1 may have a context-dependent role in placentation by negatively regulating endometrial decidualization, trophoblast EMT and invasion, which contributes to spontaneous abortion, while positively regulating endothelial function, trophoblast survival and M2-macrophage polarization, which supports pregnancy.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>SPMs are essential to preserve endothelial integrity and support trophoblast proliferation, and appear downregulated in FGR.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Preeclampsia is correlated with dysregulated SPM levels and a reduced LXA4\/TNF\u03b1 ratio, which suggests insufficient anti-inflammatory action.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Therapeutic strategies that enhance SPMs production such as aspirin and DHA supplementation show considerable promise, particularly in preventing complications in high-risk pregnancies.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00109-025-02561-w","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T15:04:35Z","timestamp":1749308675000},"page":"885-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Specialized pro-resolving mediators: key regulators in placental function and pregnancy complications"],"prefix":"10.1007","volume":"103","author":[{"given":"Luisa G.","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Georgina","family":"Correia-da-Silva","sequence":"additional","affiliation":[]},{"given":"Nat\u00e9rcia","family":"Teixeira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-5591","authenticated-orcid":false,"given":"Bruno Miguel","family":"Fonseca","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"issue":"6","key":"2561_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1210\/er.2014-1045","volume":"35","author":"B Gellersen","year":"2014","unstructured":"Gellersen B, Brosens JJ (2014) Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev 35(6):851\u2013905","journal-title":"Endocr Rev"},{"key":"2561_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.placenta.2020.01.004","volume":"102","author":"NP Illsley","year":"2020","unstructured":"Illsley NP, DaSilva-Arnold SC, Zamudio S, Alvarez M, Al-Khan A (2020) Trophoblast invasion: lessons from abnormally invasive placenta (placenta accreta). Placenta 102:61\u201366","journal-title":"Placenta"},{"key":"2561_CR3","doi-asserted-by":"crossref","unstructured":"Davies JE, Pollheimer J, Yong HE, Kokkinos MI, Kalionis B, Knofler M et al (2016) Epithelial-mesenchymal transition during extravillous trophoblast differentiation. Cell Adh Migr 10(3):310\u201321","DOI":"10.1080\/19336918.2016.1170258"},{"issue":"6","key":"2561_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","volume":"63","author":"S Saito","year":"2010","unstructured":"Saito S, Nakashima A, Shima T, Ito M (2010) Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63(6):601\u2013610","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2561_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/molehr\/gag001","volume":"9","author":"I Osman","year":"2003","unstructured":"Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA et al (2003) Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 9(1):41\u201345","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"2561_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1046\/j.1365-2249.1999.00997.x","volume":"117","author":"S Saito","year":"1999","unstructured":"Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T (1999) Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 117(3):550\u2013555","journal-title":"Clin Exp Immunol"},{"key":"2561_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2393-14-241","volume":"14","author":"RJ Phillips","year":"2014","unstructured":"Phillips RJ, Fortier MA, Bernal AL (2014) Prostaglandin pathway gene expression in human placenta, amnion and choriodecidua is differentially affected by preterm and term labour and by uterine inflammation. Bmc Pregnancy and Childbirth 14:14","journal-title":"Bmc Pregnancy and Childbirth"},{"issue":"7503","key":"2561_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510(7503):92\u2013101","journal-title":"Nature"},{"key":"2561_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2020.07.011","volume":"159","author":"AS Kim","year":"2020","unstructured":"Kim AS, Conte MS (2020) Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Adv Drug Deliv Rev 159:170\u2013179","journal-title":"Adv Drug Deliv Rev"},{"key":"2561_CR10","doi-asserted-by":"crossref","unstructured":"Yasukawa K, Okuno T, Yokomizo T (2020) Eicosanoids in skin wound healing. Int J Mol Sci 21(22):8435","DOI":"10.3390\/ijms21228435"},{"key":"2561_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.plefa.2017.09.017","volume":"126","author":"E Elliott","year":"2017","unstructured":"Elliott E, Hanson CK, Anderson-Berry AL, Nordgren TM (2017) The role of specialized pro-resolving mediators in maternal-fetal health. Prostaglandins Leukot Essent Fatty Acids 126:98\u2013104","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2561_CR12","doi-asserted-by":"crossref","unstructured":"Rasquel-Oliveira FS, Silva M, Martelossi-Cebinelli G, Fattori V, Casagrande R, Verri  Jr WA (2023) Specialized pro-resolving lipid mediators: endogenous roles and pharmacological activities in infections. Molecules 28(13):5032","DOI":"10.3390\/molecules28135032"},{"issue":"4","key":"2561_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1095\/biolreprod.113.116384","volume":"90","author":"D Zhang","year":"2014","unstructured":"Zhang D, Li Y, Peng H, Liu H, Cheng Q, Cheng X et al (2014) Glucocorticoids sensitize rat placental inflammatory responses via inhibiting lipoxin A4 biosynthesis1. Biol Reprod 90(4):74","journal-title":"Biol Reprod"},{"issue":"10","key":"2561_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/01.CIR.0000140985.89766.CB","volume":"110","author":"PY von der Weid","year":"2004","unstructured":"von der Weid PY, Hollenberg MD, Fiorucci S, Wallace JL (2004) Aspirin-triggered, cyclooxygenase-2\u2013dependent lipoxin synthesis modulates vascular tone. Circulation 110(10):1320\u20131325","journal-title":"Circulation"},{"issue":"8","key":"2561_CR15","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1194\/jlr.M039842","volume":"54","author":"ML Jones","year":"2013","unstructured":"Jones ML, Mark PJ, Keelan JA, Barden A, Mas E, Mori TA et al (2013) Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J Lipid Res 54(8):2247\u20132254","journal-title":"J Lipid Res"},{"issue":"9","key":"2561_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00011-020-01358-6","volume":"69","author":"M Szczuko","year":"2020","unstructured":"Szczuko M, Palma J, Kikut J, Komorniak N, Zietek M (2020) Changes of lipoxin levels during pregnancy and the monthly-cycle, condition the normal course of pregnancy or pathology. Inflamm Res 69(9):869\u2013881","journal-title":"Inflamm Res"},{"issue":"4","key":"2561_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3109\/10641955.2014.931419","volume":"33","author":"W Dong","year":"2014","unstructured":"Dong W, Yin L (2014) TNF\u03b1 and IL-1\u03b2 in maternal peripheral blood, umbilical cord blood and placenta, and their significance in pre-eclampsia. Hypertens Pregnancy 33(4):449\u2013456","journal-title":"Hypertens Pregnancy"},{"issue":"4\u20135","key":"2561_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.plefa.2012.08.003","volume":"87","author":"AM Gil-Villa","year":"2012","unstructured":"Gil-Villa AM, Norling LV, Serhan CN, Cordero D, Rojas M, Cadavid A (2012) Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma. Prostaglandins Leukot Essent Fatty Acids 87(4\u20135):127\u2013134","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"2561_CR19","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s43032-021-00800-2","volume":"29","author":"M Han","year":"2022","unstructured":"Han M, Lai S, Ge Y, Zhou X, Zhao J (2022) Changes of lipoxin A4 and the anti-inflammatory role during parturition. Reprod Sci 29(4):1332\u20131342","journal-title":"Reprod Sci"},{"issue":"5","key":"2561_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.12891\/ceog17902014","volume":"41","author":"H Tang","year":"2014","unstructured":"Tang H, Zhong LL, Zhang XY, Awale R, Su S, Huang LL (2014) Expression of anti-inflammatory mediator lipoxin A4 and inflammation responsive transcriptive factors NF-kappa B in patients with preeclampsia. Clin Exp Obstet Gynecol 41(5):561\u2013566","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"2","key":"2561_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1530\/REP-11-0021","volume":"142","author":"LJ Macdonald","year":"2011","unstructured":"Macdonald LJ, Boddy SC, Denison FC, Sales KJ, Jabbour HN (2011) A role for lipoxin A(4) as an anti-inflammatory mediator in the human endometrium. Reproduction 142(2):345\u2013352","journal-title":"Reproduction"},{"issue":"10","key":"2561_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/ajh\/hpw053","volume":"29","author":"LO Perucci","year":"2016","unstructured":"Perucci LO, Santos PC, Ribeiro LS, Souza DG, Gomes KB, Dusse LM et al (2016) Lipoxin A4 is increased in the plasma of preeclamptic women. Am J Hypertens 29(10):1179\u20131185","journal-title":"Am J Hypertens"},{"key":"2561_CR23","doi-asserted-by":"publisher","unstructured":"Shanmugalingam R, Wang X, Motum P, Fulcher I, Lee G, Kumar R, et al (2020) The 15-epilipoxin-A4 pathway with prophylactic aspirin in preventing preeclampsia: a longitudinal cohort study. J Clin Endocrinol Metab 105(12). https:\/\/doi.org\/10.1210\/clinem\/dgaa642","DOI":"10.1210\/clinem\/dgaa642"},{"issue":"1","key":"2561_CR24","doi-asserted-by":"publisher","first-page":"S672","DOI":"10.1016\/j.ajog.2022.11.1130","volume":"228","author":"K Vignes","year":"2023","unstructured":"Vignes K, Chilukuri P, Cockerham C, Srinivasan A, Whitley W, Huang H et al (2023) Aspirin-triggered lipoxins in high-risk pregnancy: a dose-effect comparison. Am J Obstet Gynecol 228(1):S672\u2013S673","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2561_CR25","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.4049\/jimmunol.1202807","volume":"190","author":"Z Xu","year":"2013","unstructured":"Xu Z, Zhao J, Zhang H, Ke T, Xu P, Cai W et al (2013) Spontaneous miscarriages are explained by the stress\/glucocorticoid\/lipoxin A4 axis. J Immunol 190(12):6051\u20136058","journal-title":"J Immunol"},{"issue":"2","key":"2561_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1096\/fj.10-170340","volume":"25","author":"D Maldonado-Perez","year":"2011","unstructured":"Maldonado-Perez D, Golightly E, Denison FC, Jabbour HN, Norman JE (2011) A role for lipoxin A4 as anti-inflammatory and proresolution mediator in human parturition. FASEB J 25(2):569\u2013575","journal-title":"FASEB J"},{"issue":"1","key":"2561_CR27","doi-asserted-by":"publisher","first-page":"17049","DOI":"10.1038\/s41598-019-53448-z","volume":"9","author":"MT Aung","year":"2019","unstructured":"Aung MT, Yu Y, Ferguson KK, Cantonwine DE, Zeng L, McElrath TF et al (2019) Prediction and associations of preterm birth and its subtypes with eicosanoid enzymatic pathways and inflammatory markers. Sci Rep 9(1):17049","journal-title":"Sci Rep"},{"issue":"2","key":"2561_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/molehr\/gax067","volume":"24","author":"M Lappas","year":"2018","unstructured":"Lappas M, McCracken S, McKelvey K, Lim R, James J, Roberts CT et al (2018) Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction. Mol Hum Reprod 24(2):94\u2013109","journal-title":"Mol Hum Reprod"},{"issue":"20","key":"2561_CR29","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1042\/CS20180796","volume":"132","author":"CY Chen","year":"2018","unstructured":"Chen CY, Chen CY, Liu CC, Chen CP (2018) Omega-3 polyunsaturated fatty acids reduce preterm labor by inhibiting trophoblast cathepsin S and inflammasome activation. Clin Sci (Lond) 132(20):2221\u20132239","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"2561_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/00365513.2024.2338739","volume":"84","author":"Y Han","year":"2024","unstructured":"Han Y, Wang D, Cai S, Zhang L, Xue J (2024) Resolvin D1 level during different trimesters of pregnancy for predicting the risk of fetal growth retardation in elderly pregnancy. Scand J Clin Lab Invest 84(3):154\u2013159","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"2561_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100377","volume":"64","author":"DJ Stephenson","year":"2023","unstructured":"Stephenson DJ, MacKnight HP, Hoeferlin LA, Washington SL, Sawyers C, Archer KJ et al (2023) Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy. J Lipid Res 64(6):100377","journal-title":"J Lipid Res"},{"issue":"2","key":"2561_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13206","volume":"83","author":"L Oliveira Perucci","year":"2020","unstructured":"Oliveira Perucci L, Pereira Santos TA, Campi Santos P, Ribeiro Teixeira LC, Nessralla Alpoim P, Braga Gomes K et al (2020) Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma. Am J Reprod Immunol 83(2):e13206","journal-title":"Am J Reprod Immunol"},{"key":"2561_CR33","doi-asserted-by":"crossref","unstructured":"Li A, Li S, Zhang C, Fang Z, Sun Y, Peng Y et al (2021) FPR2 serves a role in recurrent spontaneous abortion by regulating trophoblast function via the PI3K\/AKT signaling pathway. Mol Med Rep 24(6):838","DOI":"10.3892\/mmr.2021.12478"},{"key":"2561_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2024.102619","volume":"201","author":"LG Sousa","year":"2024","unstructured":"Sousa LG, Alves P, Teixeira N, Correia-da-Silva G, Fonseca BM (2024) Alterations in the pro-resolving lipid mediator machinery within first trimester maternal tissue: implications in decidualization and miscarriage risk. Prostaglandins Leukot Essent Fatty Acids 201:102619","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"2561_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13107","volume":"81","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhao S, Zhou T, Liao T, Huang X, Xiang H et al (2019) Lipoxin A4 interferes with embryo implantation via suppression of epithelial-mesenchymal transition. Am J Reprod Immunol 81(5):e13107","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"2561_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1530\/REP-12-0469","volume":"145","author":"J Xiong","year":"2013","unstructured":"Xiong J, Zeng P, Cheng X, Miao S, Wu L, Zhou S et al (2013) Lipoxin A 4 blocks embryo implantation by controlling estrogen receptor a activity. Reproduction 145(4):411\u2013420","journal-title":"Reproduction"},{"issue":"22","key":"2561_CR37","doi-asserted-by":"publisher","first-page":"13397","DOI":"10.1111\/jcmm.15963","volume":"24","author":"A Li","year":"2020","unstructured":"Li A, Zhang L, Li J, Fang Z, Li S, Peng Y et al (2020) Effect of RvD1\/FPR2 on inflammatory response in chorioamnionitis. J Cell Mol Med 24(22):13397\u201313407","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2561_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41419-020-2281-y","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu H, Cheng F, Xu Q, Huang W, Wang S, Sun R et al (2020) Lipoxin A(4) suppresses angiotensin II type 1 receptor autoantibody in preeclampsia via modulating caspase-1. Cell Death Dis 11(1):78","journal-title":"Cell Death Dis"},{"issue":"10","key":"2561_CR39","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.placenta.2013.07.007","volume":"34","author":"F Lin","year":"2013","unstructured":"Lin F, Yu X, Zhang X, Guo Y, Huang Y, Zhou J et al (2013) A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats. Placenta 34(10):941\u2013948","journal-title":"Placenta"},{"key":"2561_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3389\/fphar.2020.01131","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu H, Huang W, Chen L, Xu Q, Ye D, Zhang D (2020) Glucocorticoid exposure induces preeclampsia via dampeninglipoxin A(4), an endogenous anti-inflammatory and proresolving mediator. Front Pharmacol 11:1131","journal-title":"Front Pharmacol"},{"issue":"1","key":"2561_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.fertnstert.2014.03.056","volume":"102","author":"Z Xu","year":"2014","unstructured":"Xu Z, Zhao F, Lin F, Xiang H, Wang N, Ye D et al (2014) Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator. Fertil Steril 102(1):282-290.e4","journal-title":"Fertil Steril"},{"key":"2561_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.placenta.2020.05.003","volume":"96","author":"C Sun","year":"2020","unstructured":"Sun C, Groom KM, Oyston C, Chamley LW, Clark AR, James JL (2020) The placenta in fetal growth restriction: what is going wrong? Placenta 96:10\u201318","journal-title":"Placenta"},{"issue":"4","key":"2561_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/AOG.0b013e318187d034","volume":"112","author":"NG Pedersen","year":"2008","unstructured":"Pedersen NG, Figueras F, Wojdemann KR, Tabor A, Gardosi J (2008) Early fetal size and growth as predictors of adverse outcome. Obstet Gynecol 112(4):765\u2013771","journal-title":"Obstet Gynecol"},{"key":"2561_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/280402","volume":"2010","author":"PY Chan","year":"2010","unstructured":"Chan PY, Morris JM, Leslie GI, Kelly PJ, Gallery ED (2010) The long-term effects of prematurity and intrauterine growth restriction on cardiovascular, renal, and metabolic function. Int J Pediatr 2010:280402","journal-title":"Int J Pediatr"},{"issue":"20","key":"2561_CR45","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1080\/14767058.2016.1254182","volume":"30","author":"M Lipa","year":"2017","unstructured":"Lipa M, Bomba-Opon D, Lipa J, Bartnik P, Bartoszewicz Z, Wielgos M (2017) Lipoxin A(4) (LXA(4)) as a potential first trimester biochemical marker of intrauterine growth disorders. J Matern Fetal Neonatal Med 30(20):2495\u20132497","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2561_CR46","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1100\/tsw.2011.98","volume":"11","author":"H Pang","year":"2011","unstructured":"Pang H, Yi P, Wu P, Liu Z, Liu Z, Gong J et al (2011) Effect of lipoxin A4 on lipopolysaccharide-induced endothelial hyperpermeability. ScientificWorldJournal 11:1056\u20131067","journal-title":"ScientificWorldJournal"},{"key":"2561_CR47","doi-asserted-by":"publisher","unstructured":"Murthi P, Rajaraman G, Erwich J, Dimitriadis E (2020) Decreased placental FPR2 in early pregnancies that later developed small-for-gestation age: a potential role of FPR2 in the regulation of epithelial-mesenchymal transition. Cells 9(4)921.https:\/\/doi.org\/10.3390\/cells9040921","DOI":"10.3390\/cells9040921"},{"issue":"2","key":"2561_CR48","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.38934","volume":"67","author":"AM Alvarez","year":"2015","unstructured":"Alvarez AM, Mulla MJ, Chamley LW, Cadavid AP, Abrahams VM (2015) Aspirin-triggered lipoxin prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions. Arthritis Rheumatol 67(2):488\u2013497","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2561_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tjog.2019.11.016","volume":"59","author":"S Farhat","year":"2020","unstructured":"Farhat S, Zafar MU, Sheikh MA, Qasim CM, Urooj F, Fatima SS (2020) Association of resolvin level in pregnant women with preeclampsia and metabolic syndrome. Taiwan J Obstet Gynecol 59(1):105\u2013108","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"5","key":"2561_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11906-020-1033-9","volume":"22","author":"V Di Leo","year":"2020","unstructured":"Di Leo V, Capaccio F, Gesualdo L (2020) Preeclampsia and glomerulonephritis: a bidirectional association. Curr Hypertens Rep 22(5):36","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"2561_CR51","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1161\/HYPERTENSIONAHA.122.19244","volume":"79","author":"X Liu","year":"2022","unstructured":"Liu X, Fei H, Yang C, Wang J, Zhu X, Yang A et al (2022) Trophoblast-derived extracellular vesicles promote preeclampsia by regulating macrophage polarization. Hypertension 79(10):2274\u20132287","journal-title":"Hypertension"},{"issue":"8","key":"2561_CR52","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.3390\/cimb45080391","volume":"45","author":"S Tabacco","year":"2023","unstructured":"Tabacco S, Ambrosii S, Polsinelli V, Fantasia I, D\u2019Alfonso A, Ludovisi M et al (2023) Pre-eclampsia: from etiology and molecular mechanisms to clinical tools-a review of the literature. Curr Issues Mol Biol 45(8):6202\u20136215","journal-title":"Curr Issues Mol Biol"},{"key":"2561_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clinbiochem.2021.09.002","volume":"98","author":"LO Perucci","year":"2021","unstructured":"Perucci LO, de Castro Pinto KM, da Silva SPG, Lage EM, Teixeira PG, Barbosa AS et al (2021) Longitudinal assessment of leukotriene B4, lipoxin A4, and resolvin D1 plasma levels in pregnant women with risk factors for preeclampsia. Clin Biochem 98:24\u201328","journal-title":"Clin Biochem"},{"issue":"8","key":"2561_CR54","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/1440-1681.13095","volume":"46","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zu L, Cai W, Cheng Q, Hua T, Peng L et al (2019) Metabolomics revealed decreased level of omega-3 PUFA-derived protective eicosanoids in pregnant women with pre-eclampsia. Clin Exp Pharmacol Physiol 46(8):705\u2013710","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"2561_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13207","volume":"83","author":"AM Gil-Villa","year":"2020","unstructured":"Gil-Villa AM, Alvarez AM, Velasquez-Berrio M, Rojas-Lopez M, Cadavid JA (2020) Role of aspirin-triggered lipoxin A4, aspirin, and salicylic acid in the modulation of the oxidative and inflammatory responses induced by plasma from women with pre-eclampsia. Am J Reprod Immunol 83(2):e13207","journal-title":"Am J Reprod Immunol"},{"key":"2561_CR56","doi-asserted-by":"crossref","unstructured":"Nirgudkar PA, Arif HJ, Rosenzweig JM, Mozurkewich EL (2016) Burd I. 11: Aspirin triggered-resolvin D1 (AT-RvD1) inhibits inflammation-induced preterm birth (IIPTB) in a mouse model. Am J Obstet Gynecol 214(1):S9","DOI":"10.1016\/j.ajog.2015.10.033"},{"key":"2561_CR57","doi-asserted-by":"crossref","unstructured":"Gonzalez-Brown VM, Kniss D, Cackovic M, Landon MB, Rood KM (2020) 763: Aspirin-triggered lipoxin A4 is diminished in obese pregnant women at risk for developing preeclampsia. Am J Obstet Gynecol 222(1):S483","DOI":"10.1016\/j.ajog.2019.11.777"},{"key":"2561_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.preghy.2021.09.003","volume":"26","author":"VM Gonzalez-Brown","year":"2021","unstructured":"Gonzalez-Brown VM, Ma\u2019ayeh M, Kniss DA, Cackovic M, Landon MB, Rood KM (2021) Low-dose aspirin increases 15-epi-lipoxins A(4) in pregnancies at high-risk for developing preeclampsia. Pregnancy Hypertens 26:75\u201378","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"2561_CR59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/REP-14-0549","volume":"149","author":"JA Keelan","year":"2015","unstructured":"Keelan JA, Mas E, D\u2019Vaz N, Dunstan JA, Li S, Barden AE et al (2015) Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction 149(2):171\u2013178","journal-title":"Reproduction"},{"issue":"5","key":"2561_CR60","doi-asserted-by":"publisher","first-page":"8024","DOI":"10.3390\/ijms15058024","volume":"15","author":"E Pietrantoni","year":"2014","unstructured":"Pietrantoni E, Del Chierico F, Rigon G, Vernocchi P, Salvatori G, Manco M et al (2014) Docosahexaenoic acid supplementation during pregnancy: a potential tool to prevent membrane rupture and preterm labor. Int J Mol Sci 15(5):8024\u20138036","journal-title":"Int J Mol Sci"},{"key":"2561_CR61","doi-asserted-by":"crossref","unstructured":"Nordgren TM, Anderson Berry A, Van Ormer M, Zoucha S, Elliott E, Johnson R et al (2019) Omega-3 fatty acid supplementation, pro-resolving mediators, and clinical outcomes in maternal-infant pairs. Nutrients 11(1):98","DOI":"10.3390\/nu11010098"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02561-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:57:18Z","timestamp":1757188638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02561-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2561"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02561-w","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}